A detailed history of Cpwm, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cpwm, LLC holds 8,020 shares of LLY stock, worth $6.38 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
8,020
Previous 8,506 5.71%
Holding current value
$6.38 Million
Previous $2.76 Million 5.98%
% of portfolio
0.24%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $144,089 - $164,204
-486 Reduced 5.71%
8,020 $2.59 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $297,683 - $349,524
-1,068 Reduced 11.16%
8,506 $2.76 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $15,958 - $19,832
68 Added 0.72%
9,574 $2.74 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $664 - $818
-3 Reduced 0.03%
9,506 $2.2 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $361 - $467
2 Added 0.02%
9,509 $2.18 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $821 - $1,063
5 Added 0.05%
9,507 $1.78 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $24,004 - $31,763
184 Added 1.97%
9,502 $1.6 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $89,925 - $104,014
-615 Reduced 6.19%
9,318 $1.38 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $79,669 - $95,881
584 Added 6.25%
9,933 $1.63 Million
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $7,738 - $9,577
65 Added 0.7%
9,349 $1.3 Million
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $80,938 - $100,249
757 Added 8.88%
9,284 $1.22 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $5,659 - $6,156
53 Added 0.63%
8,527 $954,000
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $5,539 - $6,466
-50 Reduced 0.59%
8,474 $939,000
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $7,346 - $8,647
-66 Reduced 0.77%
8,524 $1.11 Million
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $7,730 - $8,660
-73 Reduced 0.84%
8,590 $994,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $9,959 - $12,447
116 Added 1.36%
8,663 $930,000
Q2 2018

Dec 21, 2018

BUY
$75.7 - $86.88 $280,544 - $321,977
3,706 Added 76.55%
8,547 $729,000
Q2 2018

Aug 09, 2018

SELL
$75.7 - $86.88 $280,165 - $321,542
-3,701 Reduced 43.33%
4,841 $413,000
Q1 2018

Dec 21, 2018

BUY
$74.21 - $87.6 $385,446 - $454,994
5,194 Added 155.14%
8,542 $661,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $111,314 - $131,400
-1,500 Reduced 30.94%
3,348 $259,000
Q4 2017

Feb 02, 2018

BUY
$81.94 - $87.89 $21,058 - $22,587
257 Added 5.6%
4,848 $409,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $123,774 - $137,377
-1,606 Reduced 25.92%
4,591 $393,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,197
6,197 $510,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cpwm, LLC Portfolio

Follow Cpwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.